Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal Women
- 28 August 1997
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (9) , 595-601
- https://doi.org/10.1056/nejm199708283370903
Abstract
Postmenopausal estrogen therapy has favorable effects on serum lipoproteins in women with normal serum lipid levels, but the effect of combined estrogen and progestin therapy on lipoproteins in women with hypercholesterolemia has not been determined, nor has it been directly compared with the effect of conventional lipid-lowering therapy.Keywords
This publication has 34 references indexed in Scilit:
- Effects of conjugated estrogens alone and combined with pravastatin for management of hypercholesterolemia in postmenopausal womenJournal of the American College of Cardiology, 1996
- Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal womenJournal of Internal Medicine, 1995
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Plasma lipoprotein levels as predictors of cardiovascular death in womenArchives of internal medicine (1960), 1993
- The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal womenArchives of internal medicine (1960), 1993
- Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemiaThe American Journal of Cardiology, 1993
- A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in womenAtherosclerosis, 1992
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987